Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer
Authors
Keywords
-
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-25
DOI
10.1186/s12951-021-01085-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunogenic Hybrid Nanovesicles of Liposomes and Tumor-Derived Nanovesicles for Cancer Immunochemotherapy
- (2021) Mei Hu et al. ACS Nano
- Screening for Lung Cancer
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metabolic Codependencies in the Tumor Microenvironment
- (2021) Prasenjit Dey et al. Cancer Discovery
- Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles
- (2021) Chunai Gong et al. JOURNAL OF NANOBIOTECHNOLOGY
- Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives
- (2021) Anselm F. L. Schneider et al. Nature Chemistry
- The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
- (2021) Shimin Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy
- (2020) Yanjie Liu et al. NANO LETTERS
- Lactate as a fulcrum of metabolism
- (2020) George A. Brooks Redox Biology
- Reduction/Oxidation-Responsive Hierarchical Nanoparticles with Self-Driven Degradability for Enhanced Tumor Penetration and Precise Chemotherapy
- (2020) Shaoping Yin et al. ACS Applied Materials & Interfaces
- Tailored Reconstituted Lipoprotein for Site-Specific and Mitochondria-Targeted Cyclosporine A Delivery to Treat Traumatic Brain Injury
- (2020) Lepei Chen et al. ACS Nano
- Size-adaptable and ligand (biotin)-sheddable nanocarriers equipped with avidin scavenging technology for deep tumor penetration and reduced toxicity
- (2020) Ya Jin et al. JOURNAL OF CONTROLLED RELEASE
- Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy
- (2020) Chunai Gong et al. JOURNAL OF NANOBIOTECHNOLOGY
- Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
- (2020) Elizabeth Varghese et al. Cancers
- Bacterial Vesicle-Cancer Cell Hybrid Membrane-Coated Nanoparticles for Tumor Specific Immune Activation and Photothermal Therapy
- (2020) Dongdong Wang et al. ACS Applied Materials & Interfaces
- Power of two: Combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
- (2020) Kalpana Tilekar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs
- (2020) Joshua Kapere Ochieng et al. ONCOGENE
- Small interfering RNA for cancer treatment: overcoming hurdles in delivery
- (2020) Nitin Bharat Charbe et al. Acta Pharmaceutica Sinica B
- Delicately Designed Cancer Cell Membrane-Camouflaged Nanoparticles for Targeted 19F MR/PA/FL Imaging-Guided Photothermal Therapy
- (2020) Sha Li et al. ACS Applied Materials & Interfaces
- Erythroliposomes: Integrated Hybrid Nanovesicles Composed of Erythrocyte Membranes and Artificial Lipid Membranes for Pore-Forming Toxin Clearance
- (2019) Yuwei He et al. ACS Nano
- Advanced-Stage Non–Small Cell Lung Cancer: Advances in Thoracic Oncology 2018
- (2019) Jordi Remon et al. Journal of Thoracic Oncology
- Engineering Biomimetic Platesomes for pH‐Responsive Drug Delivery and Enhanced Antitumor Activity
- (2019) Guangna Liu et al. ADVANCED MATERIALS
- Prevention and Early Detection for NSCLC: Advances in Thoracic Oncology 2018
- (2019) Haval Balata et al. Journal of Thoracic Oncology
- Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
- (2019) Byungji Kim et al. ADVANCED MATERIALS
- Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
- (2019) Chunai Gong et al. JOURNAL OF NANOBIOTECHNOLOGY
- The Acidic Tumor Microenvironment as a Driver of Cancer
- (2019) Ebbe Boedtkjer et al. Annual Review of Physiology
- Near-infrared boosted ROS responsive siRNA delivery and cancer therapy with sequentially peeled upconversion nano-onions
- (2019) Yuling He et al. BIOMATERIALS
- A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer
- (2019) Ke Huang et al. Cell Metabolism
- Charge-reversal nanocarriers: An emerging paradigm for smart cancer nanomedicine
- (2019) Mingzhen Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Quantitative Assessment of Nanoparticle Biodistribution by Fluorescence Imaging, Revisited
- (2018) Fanfei Meng et al. ACS Nano
- Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy
- (2018) Arunkumar Pitchaimani et al. BIOMATERIALS
- Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis
- (2018) Qian Sun et al. CELL DEATH AND DIFFERENTIATION
- Disulfide bond based polymeric drug carriers for cancer chemotherapy and relevant redox environments in mammals
- (2018) Pei Zhang et al. MEDICINAL RESEARCH REVIEWS
- Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
- (2018) Susmita Mondal et al. INTERNATIONAL JOURNAL OF CANCER
- Cell-Penetrating Peptides Transport Noncovalently Linked Thermally Activated Delayed Fluorescence Nanoparticles for Time-Resolved Luminescence Imaging
- (2018) Zece Zhu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Mannose impairs tumour growth and enhances chemotherapy
- (2018) Pablo Sierra Gonzalez et al. NATURE
- Worm-Like Biomimetic Nanoerythrocyte Carrying siRNA for Melanoma Gene Therapy
- (2018) Yanming Wang et al. Small
- Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells
- (2017) Jia Qu et al. JOURNAL OF CELL BIOLOGY
- Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment
- (2017) Chunai Gong et al. JOURNAL OF CONTROLLED RELEASE
- Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
- (2017) Xiaoguang Li et al. Frontiers in Pharmacology
- Rapamycin/DiR loaded lipid-polyaniline nanoparticles for dual-modal imaging guided enhanced photothermal and antiangiogenic combination therapy
- (2016) Jinping Wang et al. JOURNAL OF CONTROLLED RELEASE
- Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer
- (2016) X.C. Peng et al. Journal of Proteomics
- First-line erlotinib versus gemcitabine/cisplatin in patients with advancedEGFRmutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
- (2015) Y.-L. Wu et al. ANNALS OF ONCOLOGY
- High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
- (2014) Gregory M. Alushin et al. CELL
- Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
- (2014) Yi-Long Wu et al. LANCET ONCOLOGY
- Near-infrared light triggered photodynamic therapy in combination with gene therapy using upconversion nanoparticles for effective cancer cell killing
- (2014) Xin Wang et al. Nanoscale
- Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy
- (2013) Jin-Zhi Du et al. BIOTECHNOLOGY ADVANCES
- The quest to overcome resistance to EGFR-targeted therapies in cancer
- (2013) Curtis R Chong et al. NATURE MEDICINE
- Non-Small-Cell Lung Cancer: Treatment of Late Stage Disease: Chemotherapeutics and New Frontiers
- (2013) Ronald Scheff et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth
- (2012) Taro Hitosugi et al. CANCER CELL
- Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma
- (2010) Fenglian Ren et al. Molecular Cancer
- Charge‐Conversion Ternary Polyplex with Endosome Disruption Moiety: A Technique for Efficient and Safe Gene Delivery
- (2008) Yan Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- Identification of potential genes/proteins regulated by Tiam1 in colorectal cancer by microarray analysis and proteome analysis
- (2008) L LIU et al. CELL BIOLOGY INTERNATIONAL
- Seven challenges for nanomedicine
- (2008) Wendy R. Sanhai et al. Nature Nanotechnology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started